What is Ipca Laboratories Ltd. Quarterly Revenue?

Ipca Laboratories Ltd. Quarterly Revenue Ipca Laboratories Jun-2026 Quarterly Revenue is Rs 2,137 Cr which is growth of 20.6% YoY.

What is Ipca Laboratories Ltd. Quarterly Net Profit?

Ipca Laboratories Ltd. Quarterly Net Profit Ipca Laboratories Jun-2026 Quarterly Net Profit is Rs 373 Cr which is growth of 42.5% YoY.

What is Ipca Laboratories Ltd. Annual Revenue?

Ipca Laboratories Ltd. Annual Revenue Ipca Laboratories Mar-2026 Annual Revenue is Rs 7,431 Cr which is growth of 10.1% YoY.

What is Ipca Laboratories Ltd. Annual Net Profit?

Ipca Laboratories Ltd. Annual Net Profit Ipca Laboratories Mar-2026 Annual Net Profit is Rs 1,133 Cr which is growth of 74.0% YoY.

What is Ipca Laboratories Ltd. Total Shareholders Fund?

Ipca Laboratories Ltd. Total Shareholders Fund Ipca Laboratories Mar-2026 Total Shareholders Fund is Rs 7,979 Cr which is growth of 15.8% YoY.

What is Ipca Laboratories Ltd. Total Assets?

Ipca Laboratories Ltd. Total Assets Ipca Laboratories Mar-2026 Total Assets is Rs 9,776 Cr which is growth of 7.8% YoY.

What is Ipca Laboratories Ltd. Book Value Per Share?

Ipca Laboratories Ltd. Book Value Per Share Ipca Laboratories Mar-2026 Book Value Per Share is 315 Rs which is growth of 15.8% YoY.

What is Ipca Laboratories Ltd. ROE?

Ipca Laboratories Ltd. ROE Ipca Laboratories Mar-2026 ROE is 14% which is growth of 4.8% YoY.

What is Ipca Laboratories Ltd. Cash From Operating Activity?

Ipca Laboratories Ltd. Cash From Operating Activity Ipca Laboratories Mar-2026 Cash From Operating Activity is Rs 1,378 Cr which is growth of 0.3% YoY.

What is Ipca Laboratories Ltd. Net Cash Flow?

Ipca Laboratories Ltd. Net Cash Flow Ipca Laboratories Mar-2026 Net Cash Flow is Rs -64 Cr which is growth of -131.0% YoY.

Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494

Strong Performer, Getting Expensive

Download real time

US FDA Inspections

-23.00(-1.19%)

53.04% Gain from 52W Low

97,067

NSE+BSE Volume

NSE 09 Oct, 2026 3:31 PM (IST)

Portfolio

Alert

My Notes

Ipca Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Forecaster Analyst Estimates for Ipca Laboratories share price target, revenues, EPS, net income and more

Ipca Laboratories quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

POSITIVE
Quarterly Revenue Ipca Laboratories Jun-2026 Quarterly Revenue is Rs 2,137 Cr which is growth of 20.6% YoY.
POSITIVE
Quarterly Net Profit Ipca Laboratories Jun-2026 Quarterly Net Profit is Rs 373 Cr which is growth of 42.5% YoY.

Ipca Laboratories Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Jun '26	Mar '26	Dec '25	Sep '25	Jun '25	Mar '25	Dec '24	Sep '24	Jun '24	Mar '24	Dec '23	Sep '23	Jun '23
TOTAL_SR_Q Total Rev. ⌄	2,136.7	1,844.2	1,863	1,952.2	1,771.9	1,659.9	1,680.1	1,827.9	1,581.3	1,525.7	1,523.7	1,698.8	1,531.9
SR_Q Operating Rev.	2,119.2	1,814.4	1,845.2	1,930.3	1,746.9	1,638.4	1,662.7	1,810.9	1,565.9	1,510.6	1,506.8	1,662.7	1,488.7
OI_Q Other Income	17.4	29.9	17.8	21.9	25	21.5	17.4	17	15.4	15.1	16.9	36.1	43.2
OEXPNS_Q Operating Exp.	1,541.6	1,383.2	1,367.7	1,465.6	1,340	1,279.9	1,251.6	1,408.8	1,212.6	1,218.3	1,233.3	1,353.7	1,191.2
OEXPNS_Q Operating Exp.	1,541.6	1,383.2	1,367.7	1,465.6	1,340	1,279.9	1,251.6	1,408.8	1,212.6	1,218.3	1,233.3	1,353.7	1,191.2
OP_Q Operating Profit	577.6	431.2	477.5	464.7	406.9	358.6	411.1	402.1	353.2	292.3	273.5	309	297.5
OPMPCT_Q Operating Profit Margin %	27.26%	23.76%	25.88%	24.07%	23.29%	21.89%	24.72%	22.20%	22.56%	19.35%	18.15%	18.58%	19.99%
DEP_Q Depr.	74.6	70.3	68.6	66.9	63.1	65.2	62.8	62.7	61.3	61.8	63	61.4	60.4
INT_Q Interest	5	10.5	9.5	11.5	12.1	16.2	10.2	17.3	19.4	24.1	27.2	38.6	30.8
PBT_Q Profit Before Tax	515.4	349.9	417.2	408.3	356.8	17.2	355.5	339.2	287.9	127.3	200.2	245.1	249.6
TAX_Q Tax	142.1	87.6	113.8	103.6	94.7	82.2	88	95.1	83.8	62.5	63.2	83	83
NP_Q Net Profit	373.3	262.3	303.5	304.7	262	-65.1	267.6	244.1	204.1	64.8	136.9	162.1	166.6
EPS_adj_Q EPS Adj. latest	14.7	10.3	12	12	10.3	-2.6	10.6	9.6	8.1	2.6	5.4	6.4	6.6
NP_TTM Net profit TTM	1,243.8	1,132.5	805.2	769.3	708.7	650.8	780.6	650	568	530.4	550.5	533.8	539.5
EPS_TTM Basic EPS TTM	49	44.6	31.7	30.3	27.9	25.7	30.8	25.6	22.4	20.9	21.7	21	21.3
earnings_transcripts Earnings Transcripts
ai_summary AI Summary
results_pdf Results PDF
result_notes Result Notes	Notes	Notes	Notes	Notes		Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Ipca Laboratories competitor comparison and performance snapshot within industry

Ipca Laboratories annual results: revenue, profit, P&L, and margins as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Ipca Laboratories Mar-2026 Annual Revenue is Rs 7,431 Cr which is growth of 10.1% YoY.
POSITIVE
Annual Net Profit Ipca Laboratories Mar-2026 Annual Net Profit is Rs 1,133 Cr which is growth of 74.0% YoY.

Ipca Laboratories Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
SR_A Total Rev. Ann. ⌄	7.8%	7.4%	7,796.1	7,431.4	6,749.2	6,277.8	5,925.8	5,455.5	5,201.4	4,432.1	3,687.7	3,232.9	3,122.9	2,831.3
TotalOperatingRevenues_A Operating Rev. Ann.	8.1%	7.4%	7,709.1	7,336.8	6,677.9	6,166.5	5,814.6	5,399.4	5,139.2	4,367.4	3,633.2	3,193.4	3,102.2	2,803.7
OI_A Other Income Ann.	-5.2%	8.7%	87	94.6	71.3	111.3	111.2	56.1	62.2	64.7	54.6	39.5	20.7	27.7
OEXPNS_A Operating Exp. Ann.	4.3%	8.9%	5,758.1	5,556.5	5,152.9	4,955.1	4,902.8	4,155.8	3,625.6	3,452.7	2,940	2,751.8	2,670.3	2,530.1
OEXPNS_A Operating Exp. Ann.	4.3%	8.9%	5,758.1	5,556.5	5,152.9	4,955.1	4,902.8	4,155.8	3,625.6	3,452.7	2,940	2,751.8	2,670.3	2,530.1
OP_A Operating Profit Ann.	25%	3.3%	1,951	1,780.3	1,525	1,211.4	911.9	1,243.5	1,513.6	914.8	693.2	441.6	431.9	273.6
OPMPCT_A OPM Ann. %	15.9%	-3.8%		23.96%	22.60%	19.30%	15.39%	22.79%	29.10%	20.64%	18.80%	13.66%	13.83%	9.66%
TotalExpenses_A Total Exp. Ann. ⌄	4.3%	9%		5,868.8	5,467.9	5,322.2	5,175.3	4,367.1	3,821.4	3,647.2	3,130.4	2,950.1	2,864.7	2,719.9
OtherExpenses_A Other Exp. Ann.	7.6%	13.3%	2,095.5	2,043.8	1,780.2	1,640.5	1,640.4	1,303.1	1,094.3	1,101.2	1,028	926.5	888	880.1
EmployeeBenefitExpenses_A Employee Exp. Ann.	11.5%	11.8%	1,713.3	1,655.9	1,479.3	1,336.2	1,193.4	1,089.6	948.8	870.8	752.2	712.8	674.9	603.4
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	22.4%	3.5%		1,874.9	1,596.3	1,322.7	1,023	1,299.7	1,575.8	979.5	747.8	481.2	452.5	301.3
EBIDTPCT_A EBITDA Ann. margin %	13.5%	-3.6%		25.23%	23.65%	21.07%	17.26%	23.82%	30.30%	22.10%	20.28%	14.88%	14.49%	10.64%
INT_A Interest Ann.	-0.3%	40%	36.5	43.5	63	120.7	43.9	7.2	8.1	15.8	18.5	24	23.3	28.6
DEP_A Depr.	5.6%	7.5%	280.4	268.9	252	246.5	228.6	204.1	187.7	178.7	171.9	174.4	171	161.2
PBT_A PBT Ann.	26.9%	2.1%	1,690.8	1,532.1	999.8	822.2	750.5	1,088.4	1,380	785	557.4	282.8	258.2	111.5
TAX_A Tax Ann.	17.7%	10.8%	447	399.6	349	291.8	244.8	217.4	239.2	132.5	102.5	49.7	69.9	18.9
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	30.8%	-0.1%		1,132.5	650.8	530.4	505.7	870.9	1,140.8	652.5	454.9	233.1	188.3	92.5
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	30.8%	-0.1%	1,243.8	1,132.5	650.8	530.4	505.7	870.9	1,140.8	652.5	454.9	233.1	188.3	92.5
NETPCT_A NPM Ann. %	21.1%	-7%		15.43%	9.74%	8.60%	8.69%	16.13%	22.19%	14.93%	12.52%	7.29%	6.06%	3.29%
EPS_adj_A EPS Adj. latest Ann.	30.9%	-0.2%		44.6	25.7	20.9	19.9	34.3	45	25.7	17.9	9.2	7.4	3.7
result_notes Result Notes				Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes	Notes
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

10.1%

2Y CAGR

8.8%

3Y CAGR

7.8%

5Y CAGR

7.4%

7Y CAGR

10.5%

10Y CAGR

10.1%

Total Revenue Annual growth is stable compared to historical averages.

Net Profit Ann.

1Y CHG

74%

2Y CAGR

46.1%

3Y CAGR

30.8%

5Y CAGR

-0.1%

7Y CAGR

13.9%

10Y CAGR

28.5%

Net Profit Annual growth is higher than historical averages.

Operating Exp. Ann.

1Y CHG

7.8%

2Y CAGR

5.9%

3Y CAGR

4.3%

5Y CAGR

8.9%

7Y CAGR

9.5%

10Y CAGR

8.2%

Operating Expenses Annual Cr growth is stable compared to historical averages.

Ipca Laboratories balance sheet as of Mar 2026: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Ipca Laboratories Mar-2026 Total Shareholders Fund is Rs 7,979 Cr which is growth of 15.8% YoY.
POSITIVE
Total Assets Ipca Laboratories Mar-2026 Total Assets is Rs 9,776 Cr which is growth of 7.8% YoY.

Ipca Laboratories Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	10.7%	10.9%	7,979.4	6,891.6	6,348.7	5,877.3	5,523.3	4,752.7	3,677.5	3,136.7	2,695	2,475.1	2,283.1
EQCAP_A Equity Share Capital Ann.	0%	0%	25.4	25.4	25.4	25.4	25.4	25.4	25.3	25.3	25.2	25.2	25.2
TotalShareCapital_A Total Share Capital Ann.	0%	0%	25.4	25.4	25.4	25.4	25.4	25.4	25.3	25.3	25.2	25.2	25.2
ReservesAndSurplus_A Reserves Plus Surplus Ann.	10.8%	11%	7,954	6,866.3	6,323.3	5,851.9	5,498	4,727.4	3,640.3	3,111.4	2,669.7	2,449.9	2,257.8
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	10.8%	11%	7,954	6,866.3	6,323.3	5,851.9	5,498	4,727.4	3,640.3	3,111.4	2,669.7	2,449.9	2,257.8
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-24.9%	14.5%	377.4	759.8	790.4	891.9	604.2	191.8	265.4	307	420.1	546.5	661.7
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	1.7%	6.9%	188.7	191.2	183.1	179.5	155.1	135	140.8	146.3	158.7	168.6	155.6
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	52.6%	36.9%	50.1	28.4	14.6	14.1	12.9	10.4	15.3	1.6	1.6	1.6	1.6
CL_A Total Current Liabilities Ann. ⌄	-5.4%	5.9%	1,418.8	1,419.5	1,520.2	1,677.8	1,339.3	1,065.6	1,241.6	1,013.8	992.7	946.3	959.9
TradePayables_A Trade Payables Ann.	10.3%	2.8%	605.6	481.5	422.7	450.8	480.4	526.5	537.9	464.1	414.8	388.1	415.2
OtherCurrentLiabilities_A Other Current Liabilities Ann.	12.4%	17.3%	494.9	417.6	397.6	348.2	392.4	222.8	301.6	283.5	271.7	320.6	299.6
ShortTermProvisions_A ST Provisions Ann.	12.4%	8.4%	153.1	131.1	109.1	107.9	100.6	102.3	92.9	70.4	67.2	60.4	62.2
TL_A Total Capital Plus Liabilities Ann.	5%	10.2%	9,775.5	9,070.9	8,659.3	8,447	7,466.9	6,010.1	5,184.6	4,457.5	4,107.7	3,968	3,904.6
FixedAssets_A Fixed Assets Ann. ⌄	9.6%	10.8%	3,428.7	3,026.6	2,698.9	2,601.7	2,373.8	2,050.6	1,925.2	1,806.1	1,927.8	2,040.8	2,105.5
TangibleAssets_A Tangible Assets Ann.	6.1%	9.8%	2,934.8	2,502.8	2,502.1	2,454.6	2,057.3	1,839.8	1,798.9	1,706.4	1,816.4	1,899.7	1,927.9
IntangibleAssets_A Intangible Assets Ann.	12.5%	3.5%	34.3	33.9	21.5	24.1	27.5	28.9	42.1	33.8	38.2	46.3	48.7
CapitalWorkInProgress_A Capital Work In Progress Ann.	57.7%	19.9%	447.9	484.1	165.6	114.3	285.3	180.9	69.8	35.7	42	62.3	93.8
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	17.4%	16.2%	5,780.5	5,252.9	5,149.4	3,571.8	3,275.9	2,732.3	2,472.5	2,172	2,200.5	2,256.3	2,304.9
NonCurrentInvestments_A Non Current Investments Ann.	44%	35.8%	2,188.4	2,041.3	2,243.6	733.4	728.2	474	410.5	231.9	146.3	98	97.4
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-50.1%	-36.5%	14.4	32	88.2	115.9	63.9	139	99	117	110.5	95.3	71.7
OtherNonCurrentAssets_A Other Non Current Assets Ann.	7.2%	16.7%	149	153	118.7	120.9	110	68.8	37.9	17.1	16	22.1	30.3
CA_A Total Current Assets Ann. ⌄	-6.4%	4%	3,995	3,818.1	3,509.9	4,875.2	4,190.9	3,277.8	2,712.1	2,285.6	1,907.2	1,711.7	1,599.8
CurrentInvestments_A Current Investments Ann.	2.5%	-2.4%	348	651.9	410.6	323.3	719.3	393.8	238.3	90.4	69.4	113.6
TradeReceivables_A Trade Receivables Ann.	11.2%	10.4%	1,272.1	1,154.6	1,027.4	925.9	815.9	774.5	839.1	632.1	594.4	502	441.5
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	-40.3%	3.4%	363.2	164.5	112.9	1,706.1	593	306.9	152.4	259.8	131	17.5	162
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	241.7%	14.8%	39.9	40.4	5.4	1	7.5	20	3.2	2.1	2.1	2	2.9
OtherCurrentAssets_A Other Current Assets Ann.	0.7%	-0.1%	264.3	264.2	276.5	258.7	305.1	265.5	212.2	245.6	237.1	203	161.6
TA_A Total Assets Ann.	5%	10.2%	9,775.5	9,070.9	8,659.3	8,447	7,466.9	6,010.1	5,184.6	4,457.5	4,107.7	3,968	3,904.6
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-38.1%	6.1%	513.4	490.6	308.5	2,161.9	287.7	382.2	219.5	164.8	80.7	88	116.9
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	0%	-12.9%	10.5	10.5	10.5	10.5	10.5	20.9	20.9	20.9	20.9	20.9	20.9
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	212.5%	-	774.9	629	18.6	25.4	25.2					0.1	78.1
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

7.8%

2Y CAGR

6.2%

3Y CAGR

5Y CAGR

10.2%

7Y CAGR

11.9%

10Y CAGR

9.6%

Total Assets Annual growth is stable compared to historical averages.

Total Current Liabilities Ann.

1Y CHG

2Y CAGR

-3.4%

3Y CAGR

-5.4%

5Y CAGR

5.9%

7Y CAGR

4.9%

10Y CAGR

Total Current Liabilities Annual Cr is falling faster than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

15.8%

2Y CAGR

12.1%

3Y CAGR

10.7%

5Y CAGR

10.9%

7Y CAGR

14.3%

10Y CAGR

13.3%

Total ShareHolders Funds Annual growth is higher than historical averages.

Ipca Laboratories ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Book Value Per Share Ipca Laboratories Mar-2026 Book Value Per Share is 315 Rs which is growth of 15.8% YoY.
POSITIVE
ROE Ipca Laboratories Mar-2026 ROE is 14% which is growth of 4.8% YoY.

Ipca Laboratories Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
BVSH_A BVSH Ann.	10.7%	-3.4%	314.5	271.6	250.2	231.7	217.7	374.7	291.1	248.3	213.6	196.1	180.9
ROA_A RoA Ann. %	24.6%	-9.4%	11.58%	7.17%	6.12%	5.98%	11.66%	18.98%	12.58%	10.20%	5.67%	4.74%	2.36%
ROE_A ROE Ann. %	18.2%	-10%	14.19%	9.44%	8.35%	8.60%	15.76%	24.00%	17.74%	14.50%	8.64%	7.60%	4.05%
ROCE_A ROCE Ann. %	17.9%	-7.3%	19.21%	17.57%	15.07%	11.73%	17.87%	28.07%	20.30%	16.72%	9.84%	9.31%	4.75%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	13.3%	-3.6%	25.55%	23.90%	21.44%	17.59%	24.07%	30.66%	22.42%	20.58%	15.06%	14.58%	10.74%
PBITMargin_A EBIT Ann. Margin %	17%	-4.1%	21.89%	20.13%	17.45%	13.66%	20.29%	27.01%	18.33%	15.85%	9.60%	9.07%	4.99%
PBTMargin_A PBT Ann. Margin %	17.4%	-4.9%	20.88%	14.97%	13.33%	12.90%	20.15%	26.85%	17.97%	15.34%	8.85%	8.32%	3.97%
NETPCT_A NPM Ann. %	21.1%	-7%	15.43%	9.74%	8.60%	8.69%	16.13%	22.19%	14.93%	12.52%	7.29%	6.06%	3.29%
ASETTO_A Asset Turnover Ann. %	4.6%	-2.3%	0.8	0.8	0.7	0.7	0.8	0.9	0.9	0.9	0.8	0.8	0.7
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-1.2%	-2%	2.8	2.7	2.3	2.9	3.1	3.1	2.2	2.3	1.9	1.8	1.7
QuickRatio_A Quick Ratio Ann.	-5.6%	-1.2%	1.6	1.6	1.2	1.9	1.8	1.7	1.2	1.2	1	0.9	0.8
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	0	0.2	0.1	0.2	0.1	0.2	0.3	0.1	0.1		0.3
EarningRetention_A Earning Retention Ann. %	6.1%	0.9%	95.52%	84.41%	90.44%	79.94%	88.35%	91.11%	84.51%	97.23%	94.59%		86.36%
CashEarningRetention_A Cash Earning Retention Ann. %	3.8%	0.9%	96.38%	88.76%	93.47%	86.19%	90.57%	92.37%	87.84%	97.99%	96.91%		95.03%
CashEarningRetention_A Cash Earning Retention Ann. %	3.8%	0.9%	96.38%	88.76%	93.47%	86.19%	90.57%	92.37%	87.84%	97.99%	96.91%		95.03%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	26%	11%	40,540.1	38,795.2	32,434.4	20,273.9	27,089.4	24,053.3	17,773.9	12,485.1	8,606.9	8,378.2	7,821.6
EVPerNetSales_A EV Per Net Sales Ann.	16.3%	3.2%	5.5	5.8	5.3	3.5	5	4.7	4.1	3.4	2.7	2.7	2.8
PBV_A Price To Book Value Adjusted	-9.7%	3.6%	6.09	7.21	7.65	8.27	8.8	5.11	6.58	7.72	8.97	9.77	10.59
EVPerEBITDA_A EV Per EBITDA Ann.	2.9%	7.1%	21.6	24.3	24.5	19.8	20.8	15.3	18.2	16.7	17.9	18.5	26
MarketCapPerSales_A Market Cap Per Sales Ann.	16.3%	3.2%	5.5	5.7	5.1	3.5	5	4.7	4	3.4	2.6	2.5	2.6
RetentionRatios_A Retention Ratio Ann. %	6.1%	0.9%	95.51%	84.40%	90.43%	79.93%	88.34%	91.10%	84.50%	97.22%	94.58%		86.35%
EYield_A Earnings Yield Ann.	-	-	0	0	0	0	0	0.1	0	0	0	0	0
DEBT_CE_A Total Debt to Total Equity Ann.	-	-	0	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.3

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

50.3%

2Y CAGR

30.4%

3Y CAGR

18.2%

5Y CAGR

-10%

7Y CAGR

-0.3%

10Y CAGR

13.4%

ROE Annual % is growing faster than historical averages.

RoA Ann. %

1Y CHG

61.5%

2Y CAGR

37.6%

3Y CAGR

24.6%

5Y CAGR

-9.4%

7Y CAGR

1.8%

10Y CAGR

17.2%

RoA Annual % is growing faster than historical averages.

Current Ratio Ann.

1Y CHG

3.7%

2Y CAGR

10.3%

3Y CAGR

-1.2%

5Y CAGR

-2%

7Y CAGR

2.9%

10Y CAGR

5.1%

Current Ratio Annual growth is higher than historical averages.

Ipca Laboratories cash flow: net, operating, investing, and financing flows as of Mar 2026 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Ipca Laboratories Mar-2026 Cash From Operating Activity is Rs 1,378 Cr which is growth of 0.3% YoY.
NEGATIVE
Net Cash Flow Ipca Laboratories Mar-2026 Net Cash Flow is Rs -64 Cr which is growth of -131.0% YoY.

Ipca Laboratories Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '26	Mar '25	Mar '24	Mar '23	Mar '22	Mar '21	Mar '20	Mar '19	Mar '18	Mar '17	Mar '16
CFO_A Cash from Operating Act. Ann. ⌄	21.8%	4.7%	1,378.1	1,374.1	830.5	762.3	840.1	1,096.1	554.4	495.7	323.9	271.1	696
PBT_A PBT Ann.	26.9%	2.1%	1,532.1	999.8	822.2	750.5	1,088.4	1,380	785	557.4	282.8	258.2	111.5
INT_A Interest Ann.	-0.3%	40%	43.5	63	120.7	43.9	7.2	8.1	15.8	18.5	24	23.3	28.6
TAX_A Tax Ann.	17.7%	10.8%	399.6	349	291.8	244.8	217.4	239.2	132.5	102.5	49.7	69.9	18.9
CFI_A Cash from Investing Act. Ann.	-	-	-697	-738.8	-1,355.2	-709.6	-823.9	-559.6	-498.1	-123	-119.3	-145.6	-213.6
CFA_A Cash from Financing Act. Ann.	-	-	-745.2	-428.4	-464.9	506.4	426.1	-307.4	-132.6	-222.8	-130.4	-156.4	-414.2
NCF_A Net Cash Flow Ann. ⌄	-	-	-64.1	206.8	-989.6	559.1	442.4	229.1	-76.4	149.8	74.1	-30.8	68.2
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	-8.6%	21.6%	722.1	515.3	1,504.8	945.8	501.2	272.1	348.4	198.6	124.5	155.3	87.1
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	-24.1%	5.6%	658	722.1	515.3	1,504.8	943.5	501.2	272.1	348.4	198.6	124.5	155.3

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

0.3%

2Y CAGR

28.8%

3Y CAGR

21.8%

5Y CAGR

4.7%

7Y CAGR

15.7%

10Y CAGR

7.1%

Cash from Operating Activity Annual growth is lower than historical averages.

Ipca Laboratories investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Forecaster
Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

53.04% Gain from 52W Low

Ipca Laboratories quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

Ipca Laboratories - Forecaster

Forecaster Analyst Estimates for Ipca Laboratories share price target, revenues, EPS, net income and more